Aptar today announced their participation at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025. This is the third consecutive year that Aptar has presented at this prestigious event. Stephan Tanda, President and CEO, will present at 12:45 p.m. Eastern Standard Time. Vanessa Kanu, Executive Vice President and CFO and Gael Touya, President Aptar Pharma, will also be available.
A copy of the presentation will be made available on the Investors page at www.aptar.com.
From Formulation to Patient:
With over 70 years of proven experience, we partner with over 1,500 customers across the widest range of therapeutic areas and delivery routes to help get their new products to market – and stay there. Aptar’s decades of research, technology development, and our component manufacturing expertise, allow us to offer the broadest range of innovative drug delivery solutions to the Pharmaceutical industry. Our portfolio of value-added services can help you accelerate and derisk your drug product development process. Learn more here.
